The emphasis of this book is on mechanisms/pathways regulating the expression and actions of classical and novel tumor angiogenesis regulators, their underlying biology as well as anti-angiogenic drugs currently in use to fight different cancers. This book provides an insight on how factors such as obesity, diabetes and other metabolic disorders can influence the development and growth of cancer. It will be of interest not only to oncologists but also to a wide range of medical practitioners and researchers.